Scientific Reports (Sep 2022)

Rate of speech decline in individuals with amyotrophic lateral sclerosis

  • Marziye Eshghi,
  • Yana Yunusova,
  • Kathryn P. Connaghan,
  • Bridget J. Perry,
  • Marc F. Maffei,
  • James D. Berry,
  • Lorne Zinman,
  • Sanjay Kalra,
  • Lawrence Korngut,
  • Angela Genge,
  • Annie Dionne,
  • Jordan R. Green

DOI
https://doi.org/10.1038/s41598-022-19651-1
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Although speech declines rapidly in some individuals with amyotrophic lateral sclerosis (ALS), longitudinal changes in speech have rarely been characterized. The study objectives were to model the rate of decline in speaking rate and speech intelligibility as a function of disease onset site, sex, and age at onset in 166 individuals with ALS; and estimate time to speech loss from symptom onset. We also examined the association between clinical (speaking rate/intelligibility) measures and patient-reported measures of ALS progression (ALSFRS-R). Speech measures declined faster in the bulbar-onset group than in the spinal-onset group. The rate of decline was not significantly affected by sex and age. Functional speech was still maintained at 60 months since disease onset for most patients with spinal onset. However, the time to speech loss was 23 months based on speaking rate < 120 (w/m) and 32 months based on speech intelligibility < 85% in individuals with ALS-bulbar onset. Speech measures were more responsive to functional decline than were the patient-reported measures. The findings of this study will inform future work directed toward improving speech prognosis in ALS, which is critical for determining the appropriate timing of interventions, providing appropriate counseling for patients, and evaluating functional changes during clinical trials.